George W. Booz, PhD, FAHA

George W. Booz, PhD, FAHA

Professor

Department:
SOM-Pharmacology/Toxicology

Email:
gbooz@umc.edu

Work Phone:
(601) 984-4401

Education

Thomas Jefferson University, PhD, Pharmacology1990
Drexel University Evening College, Computer Science1986
University of Pennsylvania, MS, Physiology1981
St. Joseph's University, BS, Biology1976
Weis Center for Research, Postdoctoral Fellowship (1/1/1990 - 12/31/1994)

Current Positions

Professor, School of Medicine, Department of Pharmacology / Toxicology07/2021 - Present
Graduate Faculty, School of Graduate School in the Health Sciences01/2009 - Present
The University of Mississippi Medical Center
Jackson, Mississippi 39216

Academic Appointments or Other Previous Appointments

Associate Professor, University of Mississippi Medical Center, School of Medicine, Department of Pharmacology / Toxicology11/2008 - 06/2021
Adjunct Assistant Professor, University of Mary Hardin-Baylor, Department of Biology10/2005 - 10/2006
Graduate Faculty, Texas A & M University System HSC10/2003 - 10/2008
Member, Texas A & M University System HSC, School of Medicine, Department of Medicine, Division of Pulmonary and Critical Care Medicine06/2003 - 10/2008
Assistant Professor (Cross-Appointment), Texas A & M University System HSC, School of Medicine, Department of Medical Physiology04/2003 - 01/2006
Assistant Professor, Texas A & M University System HSC, School of Medicine, Department of Internal Medicine09/2002 - 10/2008
Research Physiologist (WOC), The Central Texas Veterans Health Care System09/2000 - 10/2008
Assistant Professor (Research), Texas A & M University System HSC/Cardiovascular Research Institute, School of Medicine, Department of Internal Medicine05/1999 - 09/2002
Assistant Professor, Pennsylvania State University, School of Medicine, Department of Cellular and Molecular Physiology06/1998 - 05/1999
Instructor, Pennsylvania State University, School of Medicine, Department of Cellular and Molecular Physiology06/1997 - 06/1998
Research Scientist-1, Weis Center for Research, Geisinger Clinic06/1996 - 06/1997
Associate Scientist, Weis Center for Research, Geisinger Clinic07/1994 - 05/1996

Sponsored Program Funding

Extramural, IL-33/sST2 Axis in Cardiac Remodeling, NHLBI (Pending)04/2021 - 03/2026
Extramural, ADDUCIN, ACTIN CYTOSKELETON AND COGNITIVE IMPAIRMENTS, NATIONAL INSTITUTE ON AGING04/2019 - 01/2024
Extramural, PDE9 Inhibition as a Novel Therapeutic Opportunity for Diastolic Dysfunction, Olav Raagholt og Gerd Meidel Raagholts01/2018 - 01/2020
Extramural, ARRA Postdoc Supplement-Regulation of IL-6-Type Cytokine Cardioprotective Signaling in the Ischemic Heart, National Heart, Lung, and Blood Institute08/2009 - 07/2011
Intramural, Antioxidant Hydrogel POSS-Catechin Nanocomposites for Stem Cell Cardiac Survival, UMMC Intramural Research Support Program06/2009 - 05/2010
Extramural, Improving the Therapeutic Potential of Umbilical Cord Blood Stem Cells for Cardiac Repair, ProStem Biotech Inc.10/2008 - 09/2010
Extramural, Regulation of IL-6 Type Cytokine Cardioprotective Signaling in the Ischemic Heart, National Heart, Lung, Blood Institute07/2008 - 04/2014
Intramural, Role of JAK signaling in diabetic cardiomyopathy, S&W Research Foundation Grant06/2007 - 05/2008
Intramural, Role of Calcitonin-Gene Related Peptide in Ischemia/ReperfusionInjury, S&W Research Foundation Grant11/2006 - 11/2007
Intramural, Regulation of Non-Small Cell Cancer Apoptosis by Interferon-γ, S&W Research Foundation Grant07/2005 - 06/2006
Extramural, Role of STAT3 in Defining IL-6 Signaling in Myocardial Infarction, American Heart Association, Texas Affiliate07/2004 - 06/2006
Intramural, Antioncogenic Potential of GRIM-19 in Human Non-Small-Cell Lung Cancer Cells, S&W Research Foundation Grant03/2004 - 02/2005
Intramural, Role of STAT Transcription Factors in Apoptosis of Human Non-Small-Cell Lung Cancer Cells, S&W Research Foundation Grant10/2003 - 09/2004
Extramural, STAT3 Transcriptional Regulation of Cardiac Myocyte Growth, VA VISN1701/2003 - 12/2005
Extramural, Regulation of Cardiac Hypertrophy by Angiotensins, National Heart, Lung, and Blood Institute07/1999 - 06/2003
Extramural, Novel Signaling Pathways for Angiotensin II in The Heart, National Heart, Lung, and Blood Institute01/1998 - 12/2003
Extramural, Role of the AT2 Receptor in Angiotensin II-Induced Hypertrophy of Cardiac Myocytes, American Heart Association, Pennsylvania Affiliate01/1996 - 12/1998
Extramural, Relative Contribution of Protein Kinase C Isozymes to Hypertrophic Growth of Cardiac Myocytes, American Heart Association, Pennsylvania Affiliate01/1994 - 12/1995
Extramural, Mechanisms of Angiotensin-Induced Cardiac Hypertrophy, National Heart, Lung, and Blood Institute01/1991 - 12/1994

Publications

Journal Article

Hammoud S, Daher R, Damaj R, Booz GW, Kurdi M. Knowledge and attitude of the young population towards sudden cardiac arrest: A cross-sectional study. Am J Emerg Med. 2023 Jul 13:S0735-6757(23)00369-8.2023
Herrock O, Deer E, Amaral LM, Campbell N, Whitney D, Ingram N, Cornelius DC, Turner T, Hardy-Hardin J, Booz GW, Ibrahim T, LaMarca B. Inhibiting B cell activating factor attenuates preeclamptic symptoms in placental ischemic rats. Am J Reprod Immunol. 2023 Apr;89(4):e13693.2023
Habeichi NJ, Ghali R, Mroueh A, Kaplan A, Tannous C, Jurjus A, Amin G, Mericskay M, Booz GW, El-Yazbi A, Zouein FA. Sexual dimorphism in acute myocardial infarction-induced acute kidney injury: cardiorenal deteriorating effects of ovariectomy in premenopausal female mice. Clin Sci (Lond). 2023 Jan 13;137(1):47-63.2023
Kaplan A, Abidi E, Diab R, Ghali R, Al-Awassi H, Booz GW, Fouad A. Zouein FA. Sex Differences in Cardiac Remodeling Post Myocardial Infarction with Acute Cigarette Smoking. Biol Sex Differ. 2022 Jul 7;13(1):36.2022
Tombolesi N, Altara R, da Silva GJJ, Tannous C, Zouein FA, Stensløkken KO, Morresi A, Paolantoni M, Booz GW, Cataliotti A, Sassi P. Early cardiac-chamber-specific fingerprints in heart failure with preserved ejection fraction detected by FTIR and Raman spectroscopic techniques. Sci Rep. 2022 Mar 2;12(1):3440.2022
Travis OK, Tardo GA, Giachelli C, Siddiq S, Nguyen HT, Crosby MT, Johnson TD, Brown AK, Booz GW, Smith AN, Williams JM, Cornelius DC. Interferon γ neutralization reduces blood pressure, uterine artery resistance index, and placental oxidative stress in placental ischemic rats. Am J Physiol Regul Integr Comp Physiol. 2021 Aug 1;321(2):R112-R124.Epub 2021 Jun 2. PMID: ; PMCID: PMC8409917.2021
Kaplan A, Altara R, Manca M, Gunes HM, Cataliotti A, Booz GW, Zouein FA. Distorted Assessment of Left Atrial Size by Echocardiography in Patients with Increased Aortic Root Diameter. Egypt Heart J. 2021 Jun 26;73(1):55.2020
Duncan JW, Azubuike D, Booz GW, Fisher B, Williams JM, Fan F, Ibrahim T, LaMarca B, Cunningham Jr MW. Angiotensin II Type 1 Receptor Autoantibody Blockade Improves Cerebral Blood Flow Autoregulation, Markers of Neuroprotection, and Hypertension in a Preclinical Model of Preeclampsia. Hypertens Pregnancy. 2020 Oct 29:1-10.2020
Booz GW, Kennedy D, Bowling M, Robinson T, Azubuike D1, Fisher B, Brooks K, Chinthakuntla P, Hoang NH, Hosler JP, Cunningham Jr. MW. Angiotensin II Type 1 Receptor Agonistic Autoantibody Blockade Improves Blood Pressure and Heart Mitochondrial Function in Postpartum Placental Ischemic Rats. Biol Sex Differ. 2021 (In Press)2020
Habeichi NJ, Mroueh A, Kaplan A, Ghali R, Al-Awassi H, Tannous C, Husari A, Jurjus A, Altara R, Booz GW, El-Yazbi A, Zouein FA. Sex-Based Differences in Myocardial Infarction-Induced Kidney Damage Following Cigarette Smoking Exposure: More Renal Protection in Premenopausal Female Mice. Biosci Rep. 2020;40(6):BSR20193229.2020
Ghali R, Habeichi NJ, Kaplan A, Tannous C, Abidi E, Bekdash A, Farhat R, Itani H, Jurjus A, Booz GW, Mallat Z, Zouein FA. IL-33 Induces Type-2-Cytokine Phenotype but Exacerbates Adverse Cardiac Remodeling Post-Myocardial-Infarction with Eosinophil Recruitment, Worsened Systolic Dysfunction, and Ventricular Wall Rupture. Clin Sci (Lond). 2020;134(11):1191-1218.2020
Altara R, da Silva GJJ, Frisk M, Spelta F, Zouein FA, Louch WE, Booz GW, Cataliotti A. Cardioprotective effects of the novel compound Vastiras in a preclinical model of end-organ damage. Hypertension 2020;75(5):1195-1204.2020
Fan F, Geurts AM, Pabbidi MR, Ge Y, Zhang C, Wang S, Liu Y, Gao W, Guo Y, Li L, He X, Lv W, Muroya Y, Hirata T, Prokop J, Booz GW, Jacob HJ, Roman RJ. A Mutation in γ-Adducin Impairs Autoregulation of Renal Blood Flow and Promotes the Development of Kidney Disease. J Am Soc Nephrol. 2020;31(4):687-700.2020
Guo Y, Wang S, Liu Y, Fan L, Booz GW, Roman RJ, Chen Z, Fan F. Accelerated cerebral vascular injury in diabetes is associated with vascular smooth muscle cell dysfunction. Geroscience 2020. Mar 12. doi: 10.1007/s11357-020-00179-z.2020
Kaplan A, Abidi E, Habeichi NJ, Ghali R, Alawasi H, Fakih C, Zibara K, Kobeissy F, Husari A, Booz GW, Zouein FA. Gender-biased kidney damage in mice following exposure to tobacco cigarette smoke: More protection in premenopausal females. Physiol Rep. 2020;8(2):e14339. doi: 10.14814/phy2.14339.2020
Harhous Z, Badawi S, Bona NG, Pillot B, Augeul L, Paillard M, Booz GW, Canet-Soulas E, Ovize M, Kurdi M, Bidaux G. Critical appraisal of STAT3 pattern in adult cardiomyocytes. J Mol Cell Cardiol. 2019;131:91-100.2019
Kaplan A, Yabluchanskiy A, Ghali R, Altara R, Booz GW, Zouein FA. Cerebral Blood Flow Alteration Following Acute Myocardial Infarction in Mice. Biosci Rep. 2018;38. pii: BSR20180382.2018
Altara R, Zouein FA, Bajestani SN, Cataliotti A, Booz GW. In Silico Analysis of Differential Gene Expression in Three Common Rat Models of Diastolic Dysfunction. Front Cardiovasc Med. 2018;5:11.2018
Altara R, Harmancey R, Didion SP, Booz GW, Zouein FA. Cardiac STAT3 Deficiency Impairs Contractility and Metabolic Homeostasis in Hypertension. Front Pharmacol. 2016;7:436.2016
Altara R, Manca M, Hessel MH, Gu Y, van Vark LJ, Akkerhuis M, Staessen JA, Struijker-Boudier HAJ, Booz GW, Blankesteijn WM. CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study. J Cardiovasc Transl Res. 2016;9:302-14.2016
Zouein FA, Kurdi M, Booz GW, Fuseler JW. Applying Fractal Dimension and Image Analysis to Quantify Fibrotic Collagen Deposition and Organization in the Normal and Hypertensive Heart Microsc Microanal. 2014 Aug;20(4):1134-44.2014
Zouein FA, Duhé RJ, Arrany I, Shirey K, Hosler JP, Liu H, Saad I, Kurdi M, Booz GW Loss of STAT3 in mouse embryonic fibroblasts reveals its janus-like actions on mitochondrial function and cell viability Cytokine 66:7-16, 2014.2014
Zeng H, Vaka VR, He X, Booz GW, Chen JX. High-fat diet induces cardiac
remodelling and dysfunction: assessment of the role played by SIRT3 loss.
J Cell Mol Med. 2015 Aug;19(8):1847-56.
2014
Zouein FA, Zgheib C, Hamza S, Fuseler JW, Hall JE, Soljancic A, Lopez-Ruiz A, Kurdi M, Booz GW Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation. Hyper Res 2013;36:496-503.2013
Werner T, Dombrowski S, Zgheib C, Zouein FA, Keen HL, Kurdi M, Booz GW Elucidating functional context within microarray data by integrated transcription factor focused gene-interaction and regulatory network analysis Eur Cytokine Netw 2013;24:75-90.2013
Kurdi M, Sivakumaran V, Duhé RJ, Aon MA, Paolocci N, Booz GW Depletion of Cellular Glutathione Modulates LIF-Induced JAK1-STAT3 Signaling in Cardiac Myocytes Int J Biochem Cell Biol. 2012;44:2106-15.2012
Arany I, Reed DK, Grifoni SC, Chandrashekar K, Booz GW, Juncos LA A novel U-STAT3-dependent mechanism mediates the deleterious effects of chronic nicotine exposure on renal injury Am J Physiol Renal Physiol 2012;302:F722-9.2012
Zgheib C, Zouein FA, Chidiac R, Kurdi M, Booz GW Calyculin A Reveals Serine/Threonine Phosphatase PP1 as a Regulatory Nodal Point in Canonical STAT3 Signaling of Human Microvascular Endothelial Cells J. Interferon Cytokine Res. 2012;32:87-942012
Smith JK, Patil CN, Patlolla S, Gunter BW, Booz GW, Duhé RJ Identification of a redox-sensitive switch within the JAK2 catalytic domain Free Radic Biol Med 2012;52:1101-10.2012
Alturkmani HJ, Zgheib C, Zouein FA, Alshaaer NEF, Kurdi M, Booz GW Selenate Enhances STAT3 Transcriptional Activity in Endothelial Cells: Differential Actions of Selenate and Selenite on LIF Cytokine Signaling and Cell Viability J Inorg Biochem. 2012;109:9-15.2012
Zgheib C, Kurdi M, Zouein FA, Gunter BW, Stanley BA, Zgheib J, Romero DG, King SB, Paolocci N, Booz G W Acyloxy Nitroso Compounds Inhibit LIF Signaling in Endothelial Cells and Cardiac Myocytes: Evidence that STAT3 Signaling is Redox-Sensitive PLoS One. 2012;7:e43313.2012
Zgheib C, Zouein FA, Kurdi M, Booz GW Chronic treatment of mice with leukemia inhibitory factor does not induce cardiac remodeling but improves heart function Eur Cytokine Netw. 2012;23:191-7.2012
Kurdi M, Bowers MC, Dado J, Booz GW. Parthenolide induces a distinct pattern of oxidative stress in cardiac myocytes Free Radic Biol Med. 2007; 42:474-81, 20072007
Kurdi M, Booz GW. Evidence that IL-6-Type Cytokine Signaling in Cardiomyocytes is Inhibited by Oxidative Stress: Parthenolide Targets JAK1 Activation by Generating ROS J. Cell. Physiol. 2007; 212: 424-4312007
Kurdi M, Booz GW. Jak1 inhibition, but not Stat1 knockdown, blocks the synergistic effect of IFN-gamma on Fas-induced apoptosis of A549 human non-small cell lung cancer cells J Interferon Cytokine Res 2007; 27:23-312007
Kule CE, Karoor V, Day JNE, Thomas WG, Baker KM, Acker KA, Booz GW. Agonist-dependent internalization of the angiotensin II type one receptor (AT1): Role of C-terminus phosphorylation in recruitment of β-arrestins Reg. Peptides 120: 141-148, 20042004
Baker KM, Chernin MI, Schreiber T, Sanghi S, Haiderzaidi S, Booz GW, Dostal DE, Kumar R. Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy Reg. Peptides 120: 5-13, 20042004
Booz GW, Day NE, Baker KM. Angiotensin II effects on STAT3 phosphorylation in cardiomyocytes: Evidence for Erk-dependent Tyr705 dephosphorylation. Basic Res. Cardiol. 2003; 98: 33-382003
Steinle JJ, Booz GW, Meininger CJ, Day JNE, Granger HJ β3-Adrenergic receptors regulate retinal endothelial cell migration and proliferation J. Biol. Chem. 2003; 278: 20681-206862003
Booz GW, Day JNE, Speth R, Baker KM. Cytokine G-protein signaling crosstalk in cardiomyocytes: attenuation of Jak-STAT activation by endothelin-1 Mol. Cell. Biochem. 2002; 240:39-462002
Fukuzawa J, Booz GW, Hunt RA, Shimizu N, Karoor V, Baker KM, Dostal DE. Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3: an autocrine loop for hypertrophy Hypertension. 2000; 35: 1191-11962000
Dostal DE, Booz GW, Baker KM. Regulation of angiotensinogen gene expression and protein in neonatal rat cardiac fibroblasts by glucocorticoid and β-adrenergic stimulation Basic Res. Cardiol. 2000; 95: 485-4912000
Booz GW, Carl LL, Baker KM. Amplification of angiotensin II signaling in cardiac myocytes by adenovirus-mediated overexpression of the AT1 receptor Ann. N.Y. Acad. Sci. 1999; 874: 20-261999
Booz GW, Dostal DE, Baker KM. Paracrine actions of cardiac fibroblasts on cardiomyocytes: Implications for the cardiac renin-angiotensin system Am. J. Cardiol. 1999, 83:44H-47H1999
Thomas WG, Baker KM, Booz GW, Thekkumkara TJ. Evidence against a role for protein kinase C in the regulation of the angiotensin II (AT1A) receptor Eur. J. Pharmacol. 1996; 295: 119-1221996
Booz GW, Baker KM. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy Hypertension. 1996; 28: 635-6401996
Booz GW, Baker KM. Protein kinase C in angiotensin II signalling in cardiac fibroblasts: Role in the mitogenic response Ann. N.Y. Acad. Sci. 1995; 752: 158-1671995
Booz GW, Taher M, Baker KM, Singer HA. Angiotensin II-induces phosphatidic acid formation in neonatal rat cardiac fibroblasts: Evaluation of the roles of phospholipases C and D Mol. Cell. Biochem. 1994; 141: 135-1431994
Booz GW, Dostal DE, Singer HA, Baker KM. Involvement of protein kinase C and Ca2+ in angiotensin II-induced mitogenesis of cardiac fibroblasts Am. J. Physiol. 1994; 267: C1308-C13181994
Booz GW, Bianchi CP. 2-Deoxyglucose transport by the frog sartorius: Effects of electrical stimulation and N-carbobenzoxy-glycyl-L-phenylalaninamide Comp. Biochem. Physiol. 1993; 106A: 471-4771993
Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts Circ. Res. 1993; 72: 1245-12541993
Booz GW, Conrad KM, Hess AL, Singer HA, Baker KM. Angiotensin II binding sites on hepatocyte nuclei Endocrinology. 1992; 130:3641-36491992
Booz GW, Bianchi CP. Stimulation-enhanced 3-O-methylglucose efflux from the frog sartorius: Kinetics and properties of the system Biochim. Biophys. Acta. 1992; 1109: 132-1401992
Kleinzeller A, Booz GW, Mills JW, Ziyadeh FN. pCMBS-induced swelling of dogfish (Squalus acanthias) rectal gland cells: Role of the Na+,K+-ATPase and the cytoskeleton Biochim. Biophys. Acta. 1990; 1025: 21-311990
Feldman GM, Ziyadeh FN, Mills JW, Booz GW, Kleinzeller A. Propionate induces cell swelling and K+ accumulation in shark rectal gland Am. J. Physiol. 1989; 257: C377-C3841989
Ziyadeh FN, Feldman GM, Booz GW, Kleinzeller A. Taurine and cell volume maintenance in the shark rectal gland: Cellular fluxes and kinetics Biochim. Biophys. Acta. 1988; 943: 43-521988
Kleinzeller A, Forrest JN, Cha C-J, Goldstein J, Booz G. Cell solute composition and potassium effects in slices of the rectal gland of the dogfish shark (Squalus acanthias) J. Comp. Physiol. 1985; 155B: 145-1531985
Pritchard JB, Booz G, Kleinzeller A. Renal sugar transport in the winter flounder. VI. Reabsorption of D-mannose Am. J. Physiol. 1982; 242: F415-4221982
Pritchard JB, Booz G, Kleinzeller A. Renal sugar transport in the winter flounder. V. Secretion of 2-deoxy-D-galactose Am. J. Physiol. 1978; 234: F424-4311978

Review Article

Kaplan A, Lakkis B, El-Samadi L, Karaayvaz EB, Booz GW, Zouein FA. Cooling Down Inflammation in the Cardiovascular System via the Nicotinic Acetylcholine Receptor. J Cardiovasc Pharmacol. 2023 Aug 4.2023
Massoud GP, Hazimeh DH, Amin G, Mekary W, Khabsa J, Araji T, Fares S, Mericskay M, Booz GW, Zouein FA. Risk of thromboembolic events in non-hospitalized COVID-19 patients: A systematic review. Eur J Pharmacol. 2023 Feb 15;941:175501.2023
Smith AN, Altara R, Amin G, Habeichi NJ, Thomas DG, Jun S, Kaplan A, Booz GW, Zouein FA. Genomic, Proteomic, and Metabolic Comparisons of Small Animal Models of Heart Failure with Preserved Ejection Fraction (HFpEF): A tale of mice, rats, and cats. J Am Heart Assoc. 2022 Aug 2;11(15):e026071.2022
Kaplan A, Amin G, Abidi E, Altara R, Booz GW, Zouein FA. Role of ranolazine in heart failure: From cellular to clinic perspective. Eur J Pharmacol. 2022 Mar 15;919:174787.2022
Smith AN, Thomas DG, Tatum RE, Booz GW, Cunningham MW Jr. The Role of Mitochondrial Dysfunction in Preeclampsia: Causative Factor or Collateral Damage? Am J Hypertens. 2021 May 22;34(5):442-452. d2021
Shekhar S, Liu Y, Wang S, Zhang H, Fang X, Zhang J, Fan L, Zheng B, Roman RJ, Wang Z, Fan F, Booz GW. Novel Mechanistic Insights and Potential Therapeutic Impact of TRPC6 in Neurovascular Coupling and Ischemic Stroke. Int J Mol Sci. 2021 Feb 19;22(4):2074.2021
Jiao F, Varghese K, Wang S, Liu Y, Yu H, Booz GW, Roman RJ, Liu R, Fan F. Recent Insights Into the Protective Mechanisms of Paeoniflorin in Neurological, Cardiovascular, and Renal Diseases. J Cardiovasc Pharmacol. 2021 Jun 1;77(6):728-734.2021
da Silva GJJ, Altara R, Booz GW, Cataliotti A. Atrial Natriuretic Peptide31-67: A Novel Therapeutic Factor for Cardiovascular Diseases. Front Physiol. 2021 Jul 8;12:691407.2021
Habeichi NJ, Tannous C, Yabluchanskiy A, Altara R, Mericskay M, Booz GW, Zouein FA. Insights into the modulation of the interferon response and NAD+ in the context of COVID-19. Int Rev Immunol. 2021 Aug 11:1-11.2021
Tannous C, Booz GW, Altara R, Muhieddine DH, Mericksay M, Refaat M, Zouein FA. Nicotinamide Adenine Dinucleotide: Biosynthesis Pathways, Consuming Enzymes, and Therapeutic Role in Cardiac Diseases. Acta Physiol (Oxf). 2020 Aug 27;e13551.2020
Nourredine F, Altara R, Fan F, Yabluchanskiy A, Booz GW, Zouein FA. Impact of the Renin-Angiotensin System on the Endothelium in Vascular Dementia: Unresolved Issues and Future Perspectives. Int J Mol Sci. 2020;21(12):4268.2020
Booz GW, Altara R, Eid AH, Wehbe Z, Fares S, Zaraket H, Habeichi NJ, Zouein FA. Macrophage Responses Associated with COVID-19: A Pharmacological Perspective. Eur J Pharmacol. 2020 Sep 11;887:173547.2020
Bejjani AT, Saab SA, Muhieddine DH, Habeichi N, Booz GW, Zouein FA. Cardiac Spatiotemporal Dynamics of Major Immune Cells and Cytokines During Early Left Ventricular Remodeling Post-Myocardial Infarction in Mice. J Cardiovasc Pharmacol. 2020;75:112-122.2020
Harhous Z, Booz GW, Ovize M, Bidaux G, Kurdi M. An Update on the Multifaceted Roles of STAT3 in the Heart. Front Cardiovasc Med. 2019;6:150.2019
Shekhar S, Varghese K, Li M, Fan L, Booz GW, Roman RJ, Fan F. Conflicting Roles of 20-HETE in Hypertension and Stroke. 2019;20(18). pii: E4500.2019
Zouein FA, Booz GW, Altara R. STAT3 and Endothelial Cell – Cardiomyocyte Dialog in Cardiac Remodeling. Front Cardiovasc Med 2019 Apr 24;6:50.2019
Kurdi M, Zgheib C, Booz GW. Recent Developments on the Crosstalk Between STAT3and Inflammation in Heart Function and Disease. Front Immunol. 2018;19;9:3029.2018
Altara R, Ghali R, Mallat Z, Cataliotti A, Booz GW, Zouein FA. Conflicting Vascular and Metabolic Impact of the IL-33/sST2 Axis. 2018;114(12):1578-1594.2018
Ghali R, Altara R, Louch WE, Cataliotti A, Mallat Z, Kaplan A, Zouein FA, Booz GW. IL (Interleukin)-33/sST2 Axis in Hypertension and Heart Failure. Hypertension. 2018;72(4):818-828.2018
Shekhar S, Cunningham MW, Pabbidi MR, Wang S, Booz GW, Fan F. Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches. Eur J Pharmacol. 2018;833:531-544.2018
Zhang C, Booz GW, Yu Q, He X, Wang S, Fan F. Conflicting roles of 20-HETE in hypertension and renal end organ damage. Eur J Pharmacol. 2018 Aug 15;833:190-200.2018
Forrester SJ, Booz GW, Sigmund CD, Coffman TM, Kawai T, Rizzo V, Scalia R, Eguchi S. Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology. Physiol Rev. 2018;98(3):1627-1738.2018
Kaplan A, Abidi E, El-Yazbi A, Eid A, Booz GW, Zouein FA. Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects. Heart Fail Rev. 2018 May;23(3):419-437.2018
Lv W, Booz GW, Fan F, Wang Y, Roman RJ. Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies. Front Physiol. 2018 Feb 16;9:105.2018
Lv W, Booz GW, Wang Y, Fan F, Roman RJ. Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets. Eur J Pharmacol. 2018 Feb 5;820:65-76.2018
Lv W, Fan F, Wang Y, Gonzalez-Fernandez E, Wang C, Yang L, Booz GW, Roman RJ. Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD. Physiol Genomics. 2018;50(1):20-34.2018
Altara R, Giordano M, Nordén ES, Cataliotti A, Kurdi M, Bajestani SN, Booz GW. Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction. Front Endocrinol (Lausanne). 2017 Jul 17;8:160.2017
Kaplan A, Abidi E, Ghali R, Booz GW, Kobeissy F, Zouein FA. Functional, Cellular, and Molecular Remodeling of the Heart under Influence of Oxidative Cigarette Tobacco Smoke. Oxid Med Cell Longev. 2017;2017:3759186.2017
Kaplan A, Altara R, Eid A, Booz GW, Zouein FA. Update on the Protective Role of Regulatory T Cells in Myocardial Infarction: A Promising Therapy to Repair the Heart. J Cardiovasc Pharmacol. 2016;68:401-413.2016
Altara R, Mallat Z, Booz GW, Zouein FA. The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart. J Immunol Res. 2016;2016:4396368.2016
Fan F, Ge Y, Lv W, Elliott MR, Muroya Y, Hirata T, Booz GW, Roman RJ. Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology. Front Biosci (Landmark Ed). 2016;21:1427-14632016
Altara R, Manca M, Brandão RD, Zeidan A, Booz GW, Zouein FA. Emerging Importance of Chemokine Receptor CXCR3 and Its Ligands in Cardiovascular Diseases. Clin Sci (Lond). 2016;130:463-78.2016
Altara R, Manca M, Sabra R, Eid AA, Booz GW, Zouein FA. Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine. Heart Fail Rev. 2016;21(1):25-47.2016
Zouein FA, Altara R, Chen Q, Lesnefsky EJ, Kurdi M and Booz GW. Pivotal Importance of STAT3 in Protecting the Heart from Acute and Chronic Stress: New Advancement and Unresolved Issues. Front Cardiovasc Med 2015 Nov 30;2:36.2015
Zouein FA, Kurdi M, Booz GW LIF and the Heart: Just Another Brick in the Wall? Eur Cytokine Netw. 2013;24:11-9.2013
Zouein FA, Kurdi M, Booz GW Dancing rhinos in stilettos: The amazing saga of the genomic and nongenomic actions of STAT3 in the heart JAK-STAT 2013; 2:e24352.2013
Zouein FZ, de Castro Brás LE, da Costa DV, Lindsey ML, Kurdi M, Booz GW Heart Failure with Preserved Ejection Fraction: Emerging Drug Strategies J Cardiovasc Pharmacol 2013;62:13-21.2013
Zouein FA, Booz GW AAV-Mediated Gene Therapy Cure for Heart Failure: Enhancing Contractility and Calcium Handling F1000 2013;5:27.2013
Zgheib C, Zouein FA, Kurdi M, Booz GW Differential STAT3 Signaling in the Heart: Impact of Concurrent Signals and Oxidative Stress JAK-STAT 2012;1:102-111.2012
Zouein FA, Zgheib C, Liechty KW, Booz GW Post-Infarct biomaterials, left ventricular remodeling, and heart failure: Is good good enough? Congest Heart Failure 2012;18:284-90.2012
Booz GW Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress Free Radic Biol Med 2011;51:1054–1061.2011
Kurdi M, Booz GW New Take on the Role of Angiotensin II in Cardiac Hypertrophy and Fibrosis Hypertension 2011;57:1034-8.2011
Kurdi M, Booz GW Three 4-letter words of hypertension-related cardiac hypertrophy: TRPC, mTOR, and HDAC J Mol Cell Cardiol 2011;50:964-71.2011
Zouein FA, Duhe RJ, Booz GW JAKs go nuclear: Emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth Growth Factors 2011;29:245-522011
Kurdi M, Chidiac R, Hoemann C, Zouein F, Zgheib C, Booz GW Hydrogels as a platform for stem cell delivery to the heart Congest Heart Failure. 2010;16(3):132-135.2010
Kurdi M, Booz GW Deciphering STAT3 Signaling In the Heart: Plasticity and Vascular Inflammation Congest Heart Failure. 2010;16:234-2382010
Kurdi M, Booz GW JAK redux-A second look at the regulation and role of JAK kinases in the heart Am J Physiol Heart Circ Physiol 2009;297:H1545-56.2009
Kurdi M, Booz GW. G-CSF-based stem cell therapy for the heart--unresolved issues part B: Stem cells, engraftment, transdifferentiation, and bioengineering Congest Heart Fail. 2007; 13:347-512007
Kurdi M, Booz GW. Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling J Cardiovasc Pharmacol. 2007; 50:126-412007
Kurdi M, Booz GW. G-CSF-based stem cell therapy for the heart-unresolved issues part A: paracrine actions, mobilization, and delivery Congest Heart Fail. 2007; 13:221-72007
Booz GW. PARP inhibitors and heart failure--translational medicine caught in the act Congest Heart Fail. 2007; 13:105-122007
Kurdi M, De Mello WC, Booz GW. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components Int J Biochem Cell Biol. 2005; 37:1357-672005
Booz GW. Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory system Hypertension 2005; 45:341-62005
Booz GW, Day JNE, Baker KM Interplay between the cardiac renin angiotensin system and JAK-STAT Signaling: Role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure J. Mol. Cell. Cardiol. 34:1443-1453, 2002.2002
Booz GW, Fukuzawa J, Dostal DE, Baker KM Angiotensin and cytokine receptor crosstalk in modulation of cardiomyocyte hypertrophy Heart 33:174-179, 2001.2001
Booz GW, Baker KM Actions of angiotensin II on isolated cardiac myocytes Heart Failure Reviews 3: 125-130, 1998.1998
Dostal DE, Booz GW, Baker KM Angiotensin II signalling pathways in cardiac fibroblasts: Conventional versus novel mechanisms in mediating cardiac growth and function Mol. Cell. Biochem. 157: 15-21, 1996.1996
Booz GW, Baker KM Role of the renin-angiotensin system in the pathophysiology of cardiac remodeling Blood Pressure 5 (Suppl 2): 10-18, 1996.1996
Booz GW, Baker KM Molecular signalling mechanisms controlling the growth and function of cardiac fibroblasts Cardiovasc. Res. 30: 537-543, 1995.1995
Booz GW, Dostal DE, Baker KM Regulation of cardiac second messengers by angiotensins In: Cardiac Renin-Angiotensin System (1st ed), edited by K. Lindpaintner and D. Ganten. New York: Futura Medical Publishers, 1994, p. 101-124.1994
Dostal DE, Booz GW, Baker KM Cellular and subcellular localization of elements of the cardiac renin-angiotensin system In: Cardiac Renin-Angiotensin System (1st ed), edited by K. Lindpaintner and D. Ganten. New York: Futura Medical Publishers, 1994, p. 1-21.1994
Baker KM, Booz GW, Dostal DE Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system Ann. Rev. Physiol. 54: 227-241, 1992.1992

Abstracts

Cunningham Jr. MW, Jayaram A, Amaral LA, Chinthakuntla P, Brooks K, Booz G, Vaka VR, Ibrahim T, Deer E, Cornelius DC, LaMarca B. Tumor Necrosis Factor Alpha Blockade Improves Natural Killer Cell Activation, Hypertension, and Mitochondrial Oxidative Stress in a Preclinical Rat Model of Preeclampsia. Hypertension 2019 Scientific Session. P1110.2019
Cunningham Jr MW, Chinthakuntla P, Brooks K, Fisher B, Ibrahim T, Amaral LM, Booz GW. Angiotensin II type I receptor agonistic autoantibody blockade improves hypertension and immune activation in postpartum preeclamptic rats. Hypertension 2019.2019
Gao W, Zhang H, He X, Wang S, Ya G, Booz GW, Roman RJ, Fan F. Dual-Specificity Protein Phosphatase 5 Regulates Renal Vessel Myogenic Response via Direct Modulating Extracellular Signal-Related Kinase and Protein Kinase C. Hypertension 2019 Scientific Session. P160.2019
Guo Y, Wang S, Zhang H, Gao W, He X, Booz GW, Roman RJ, Fan F. High Glucose Induced Diabetic Dementia is Mediated by Mitochondria Dysfunction. Hypertension 2019 Scientific Session. P3016.2019
Altara R, da Silva GJJ, Frisk M, Norden ES, Spelta F, Espe EKS, Sjaastad I, Zouein FA, Louch WE, Booz GW, Cataliotti A. Cardiorenal Protective Effects of Pro-ATRIAL-NATRIURETIC-PEPTIDE (31-67) Independent of Blood Pressure. Annual ESH 2019, Milan (oral and poster). HTTPS://JOURNALS.LWW.COM/JHYPERTENSION/ABSTRACT/2019/07001/CARDIORENAL_PROTECTIVE_EFFECTS_OF.69.ASPX.2019
Altara R, da Silva GJJ, Frisk M, Norden ES, Spelta F, Espe EKS, Sjaastad I, Zouein FA, Louch WE, Booz GW, Cataliotti A. THE PROTECTIVE EFFECTS OF PRO-ATRIAL-NATRIURETIC-PEPTIDE (31-67) ON HYPERTENSION INDUCED CARDIAC AND RENAL ADVERSE REMODELING. 2019 XXIII ISHR World Congress, Beijing (poster).2019
He X, Chen CCA, Murphy SR, Booz GW, Roman RJ, Fan F. Hypertensin-induced renal injury is associated with impaired glomerular barrier function involving podocyte dysfumction. Experimental Biology 2019, Orlando, FL. The FASEB Journal 33 (1_supplement), 573.9-573.9.2019
Altara R, da Silva GJJ, Frisk M, Norden ES, Spelta F, Espe EKS, Sjaastad I, Zouein F, Louch W, Booz GW, Cataliotti A. Cardiorenal Protective Effects of ProANP31-67 Independent of Blood Pressure. Norwegian Society of Hypertension. 7 Feb. 2019, Oslo (oral).2019
Wang S, Jiao F, Guo Y, Booz G, Roman R, Fan F. Role of Vascular Smooth Muscle Cells in Diabetes-related Vascular Cognitive Impairment. Stroke, 2019.2019
Zhang C, He X, Booz GW, Roman RJ, Fan F. Knockout of Dual-Specificity Protein Phosphatase 5 Protects Against Hypertension Induced Chronic Kidney Disease. 2018 HBPR, Chicago, IL.2018
Fan F, Wang S, He X, Booz G and Roman RJ. Down Regulation of Gamma-Adducin in the Cerebral Vasculature Promotes Blood-Brain Barrier Leakage and Contributes to Hypertension-related Cognitive Deficits. 2018, 11th World Congress for Microcirculation, Vancouver, BC, Canada.2018
Zhang C, He X, Wang S, Roman RJ, Booz G and Fan F. Knockout of Dual-Specificity Protein Phosphatase 5 Protects Against Hypertension Induced Chronic Kidney Disease. Joint Hypertension 2018 Scientific Sessions, Chicago, IL.2018
Wang S, He X, Booz G, Roman RJ and Fan F. Hyperglycemia and Oxidative stress Contribute to Impaired Cerebral Autoregulation in Association with Dementia in Diabetes. 2018 Joint Hypertension 2018 Scientific Sessions, Chicago, IL.2018
Altara R, da Silva G, Frisk M, Norden E, Bergo K, Sjaastad I, Geimer T, Mahan L, Louch W, Booz GW, Cataliotti A. Cardiorenal and Humoral Actions of proANP31-67 (Vastiras®) in Diastolic Dysfunction. CHFR Symposium - Holmenkollen, Oslo Sept 2018 (poster).2018
Wang S, Feng J, He X, Booz G, Roman RJ and Fan F. Hyperglycemia induces impairment of cerebral autoregulation in association with cognitive deficits in diabetic rats. 2018 NIH, NIGMS Seveth Biennial Natioanal IDeA Symposium of Biomedical Research Excellence, Washington, D.C.2018
Wang S, Feng J, He X, Booz G, Roman RJ and Fan F. Disruption of Actin Cytoskeleton Contributes to Impairment of Cerebral Autoregulation in Association with Diabetes-related Cognitive Deficits. 2018, 11th World Congress for Microcirculation, Vancouver, BC, Canada.2018
Zouein FA, Zgheib C, do Carmo JM, Vaka R, Altara R, Kurdi M, Booz G. Abstract 110: Importance of the C-Terminal Transactivation Domain of STAT3 in Hypertension-Induced Cardiac Hypertrophy. Hypertension. 2015;66:A110. Available: http://hyper.ahajournals.org/content/66/Suppl_12015
Fuseler JW, Zouein FA, Kurdi M, Booz GW Fractal and Image Analysis of Collagen Fibrosis in Hypertensive Induced Myocardial Remodeling in Mouse Hearts Lacking STAT3 Protection Microsc Microanal. 20132013
Zouein FA, Kurdi M, Booz GW, Fuseler JW. Role of STAT3 in Collagen Deposition and Organization in the Normal and Hypertensive Heart Hypertension. 2013;62:A387.2013
Zouein FA, Zgheib C, Hamza S, Hall JE, Ruiz A, Juncos L, Booz GW DUAL ROLE OF STAT3 IN HYPERTENSION-INDUCED CARDIAC REMODELING The FASEB Journal. 2012;26:1060.19.2012
Zouein F, Zgheib C, Fuseler J, Hall JE, Kurdi M, Booz GW STAT3 Affects Myofibrillar Structure and Its Loss May Contribute to Heart Failure in Hypertension Hypertension. 2012;60:A71.2012
Zgheib C, Kurdi M, Zouein F, Zgheib J, King S, Paolocci N, Booz GW Acyloxy Nitroso Compounds Inhibit LIF Signaling in Endothelial Cells and Cardiac Myocytes: Evidence That STAT3 Signaling is Redox-Sensitive Hypertension. 2012;60:A2192012
Zouein FA, Sebastian T, Farley JM, Booz GW Transient Receptor Potential Type C Channels Play a Critical Role in Angiogenesis FASEB J 2011;25:1091.122011
Allukian M, Herdrich BJ, Xu J, Wu W, Dorsett-Martin W, Booz G, Mitchell ME, Gorman JH, Gorman RC, Liechty KW Decreased Inflammation During Cardiac Regeneration Following Fetal Myocardial Infarction (MI) Is Associated with Decreased NF-κB Expression Compared to the Adult American College of Surgeons’ 97th Annual Clinical Congress2011
Arany I, Reed D, Grifoni SC, Booz G, Juncos LA. A novel U-STAT3-dependent regulation of TGFβ1-induced renal tubular epithelial-mesenchymal transition by chronic nicotine exposure The American Society of Nephrology 20112011
Arany I, Clark K, Reed D, Booz G, Juncos LA Sex hormones modulate responses to oxidative stress in renal proximal tubule cells 2011 APS Conference: Physiology of Cardiovascular Disease: Gender Disparities2011
Zgheib C, Sebasian Tocchetti CG, Paolocci N, King SB, Kurdi M, Booz, GW. Nitroxyl activates redox-sensitive stress signaling in endothelial cells and has anti-inflammatory actions. Hypertension 2010;56:P3512010
Zgheib C, Sebastian T, Chidiac R, Keen HL, Kurdi M, Booz GW Protein phosphatase 2A (PPA2) plays a critical role determining the endothelial cell gene expression profile of leukemia inhibitory factor (LIF). Hypertension. 2010; 56:O31.2010
Alturkmani HJ, Zgheib C, Zouein FA, Kurdi M, Booz GW Sodium Selenate Enhances Endothelial Cell STAT3 Tyrosine Phosphorylation and DNA Binding Mol. Biol. Cell 2010;21:4299 (#2971/L077).2010
Kurdi M, Booz GW Oxidative stress blocks activation of JAK-STAT signaling in cardiac myocytes J. Mol. Cell. Cardiol. 42(S1):S50, 20072007
Prakash G, Booz GW Role for STAT3 in apoptosis signaling by interferon-γ in human nonsmall cell lung cancer A549 cells Proc Am Thorac Soc 3 (Abstract Issue), A175, 2006.2006
Kurdi M, Booz GW Inhibition of IL-6-type cytokine signaling by oxidative stress in cardiac myocytes J. Mol. Cell. Cardiol. 40: 883 (#95), 2006.2006
Kurdi M, Nickolai JL, Booz GW Anti-inflammatory parthenolide inhibits JAK1 activation in cardiac myocytes but induces oxidative stress J. Mol. Cell. Cardiol. 38: 845 (#99), 2005.2005
Brewer JR, Spradley C, Nickolai JL, Winn RE, Booz GW Role of STAT1 in the Permissive Effect of Interferon-γ on FAS-Induced Apoptosis of Non-Small Cell Lung Cancer Cells Chest 128: 154S, 2005.2005
Bowers M, Kurdi M, Nickolai JL, Booz GW Parthenolide induces oxidative stress in cardiomyocytes: Dfferential activation of mitochondrial and NADPH oxidases J Cardiac Failure 11 (Suppl 6): 070, i2005.2005
Kule CE, Karoor V, Day JNE, Thomas WG, Baker KM, Acker KA, Booz GW Rescue of internalization-impaired angiotensin II AT1 mutants by β-arrestin overexpression J. Am. Coll. Cardiol. 43 (Suppl A): 455A, 20042004
Salamat N, Maxwell SA, Brewer JR, Day JNE, Winn RE, Booz GW Activation of STAT1 BY IFN-γ Inhibits Growth of Human Non-Small Cell Lung Cancer Cells Chest 126 : 914S, 2004.2004
Day JNE, Booz GW The Anti-Inflammatory Agent Parthenolide has Differential and Independent Effects on Jak-STAT and ERK Signaling in Cardiac Myocytes Hypertension 44 (Oct): P9, 2004.2004
Day JNE, Booz GW. Molecular mechanisms of IL-6-related-cytokine STAT3 regulation in cardiac myocytes J Cardiac Failure 10 (Suppl 4): 121, 2004.2004
Brewer JR, Guthrie NS, Booz GW Interferon-γ has a potent cytostatic effect via STAT1 activation on the A549 human lung cancer cell line Mol Cell Biol 15: 370a (#2047), 20042004
Booz GW, Smith JD, Baker KM Angiotensin II inhibits gp130 signaling in cardiac myocytes by tyrosine phosphatase activation J. Am. Coll. Cardiol. 37 (Suppl A): 239A, 2001.2001
Fukuzawa J, Baker KM, Booz GW. Negative modulation of angiotensin II-induced Jak/STAT signaling in cardiomyocytes via stable complex formation of protein tyrosine phosphatase SHP-2 with STAT3 J. Am. Coll. Cardiol. 37 (Suppl A): 295A, 20012001
Booz GW, Day JNE, Baker KM Endothelin-1 inhibits activation of the LIF receptor in cardiomyocytes Hypertension 38: 529 (P219), 2001.2001
Fukuzawa J, Dostal DE, Booz GW, Hunt RA, Kempinski AM, Baker KM Cardiotrophin-1 induces cardiomyocyte hypertrophy through stimulation of the renin-angiotensin system J. Am. Coll. Cardiol. 2 (Suppl A):315A, 1999.1999
Booz GW, Reiprish MJ, Baker KM. AT2 receptor blockade augments angiotensin II-induced cardiomyocyte hypertrophy Hypertension 26: 547 (#61), 1995.1995
Lin C, Baker KM, Rothblum KN, Booz GW, Dostal DE Atrial natriuretic peptide regulation of renin and angiotensinogen mRNA in cultured rat ventricular cardiac fibroblasts Hypertension 26: 562 (#P64), 1995.1995
Taher MM, Booz GW, Baker KM, Singer HA. Angiotensin-induced phosphatidic acid in cardiac fibroblasts J. Mol. Cell. Cardiol. 26: CLV(Abstr. #19), 1994.1994
Thekkumkara TJ, Du J, Dostal DE, Booz GW, Motel TJ, Baker KM Characterization of permanently transfected AT1A receptors in CHO-K1 cells: Desensitization by angiotensin II FASEB J. 7: A491, 1993.1993
Booz GW, Singer HA, Baker KM. Role of protein kinase C in angiotensin II-induced mitogenesis of neonatal rat cardiac fibroblasts The Physiologist 36:A-11, 19931993
Booz G, Shetlar R, Morrison-Shetlar A. Anoxia affects the membrane cytoskeleton of flounder (Pseudopleuronectes americanus) erythrocytes Bull. Mt. Desert Isl. Biol. Lab. 31: 14-15, 1992.1992
Booz GW, Conrad KM, Hess AL, Baker KM Angiotensin II binding sites on hepatocyte nuclei FASEB J. 6: A1577, 1992.1992
Schorb W, Booz GW, Dostal DE, Chang KC, Baker KM Angiotensin II receptor mediated growth of cardiac fibroblasts Circulation 86: A189, 1992.1992
Booz GW, Kleinzeller A 2-Deoxyglucose uptake by flounder (Pseudopleuronectes americanus) erythrocytes Bull. Mt. Desert Isl. Biol. Lab. 30: 50, 19911991
Kleinzeller A, Booz GW, Ziyadeh FN The effect of medium composition on the anisoosmotic volume response of dogfish (Squalus acanthias) rectal gland cells Bull. Mt. Desert Isl. Biol. Lab. 30: 76-77, 1991.1991
Kleinzeller A, Ziyadeh FN, Booz GW, McCallum S Role of the Na, K-ATPase in the mercurial-induced swelling of dogfish (Squalus acanthias) rectal gland cells Bull. Mt. Desert Isl. Biol. Lab. 29: 67, 1990.1990
Booz GW, Kleinzeller A Hexose transport by flounder (Pseudopleuronectes americanus) erythrocytes Bull. Mt. Desert Isl. Biol. Lab. 29: 52, 1990.1990
Booz GW, Bianchi CP N-Carbobenzoxy-glycyl-L-phenylalaninamide inhibits both basal and contraction-initiated 2-deoxyglucose uptake by frog muscle FASEB J. 4: A541, 1990.1990
Ziyadeh FN, Mills JW, Booz GW, Kleinzeller A Recovery of cell volume and solute composition following potassium-induced swelling in rectal gland cells of the shark (Squalus acanthias): Properties of the system Bull. Mt. Desert Isl. Biol. Lab. 28: 68-9, 19891989
Feldman GM, Ziyadeh FN, Booz GW, Kleinzeller A Cell swelling induced by an organic anion Kidney Int. 35: 495, 19891989
Booz GW, Kleinzeller A, Payne J Hexose transport by dogfish (Squalus acanthias) and flounder (Pseudopleuronectes americanus) erythrocytes Bull. Mt. Desert Isl. Biol. Lab. 28: 47, 1989.1989
Ziyadeh FN, Feldman GM, Booz GW, Kleinzeller A Uptake of trimethylamine-N-oxide (TMAO) and trimethylamine (TMA) in skeletal muscle and rectal gland of shark (Squalus acanthias) Bull. Mt. Desert Isl. Biol. Lab. 27: 44, 1987-88.1988
Ziyadeh FN, Feldman GM, Booz GW, Kleinzeller A Taurine uptake and efflux in rectal gland cells of shark (Squalus acanthias) Bull. Mt. Desert Isl. Biol. Lab. 27: 94, 1987-88.1988
Feldman GM, Ziyadeh FN, Booz GW, Mills JW, Kleinzeller A Iso-osmotic cell swelling induced by propionate in rectal gland of shark (Squalus acanthias) Bull. Mt. Desert Isl. Biol. Lab. 27: 108-9, 1987-88.1988
Booz GW, Ziyadeh FN, Feldman GM, Kleinzeller A The binding sites involved in p-chloromercuribenzene sulfonate (PCMBS) induced swelling of dogfish (Squalus acanthias) rectal gland cells Bull. Mt. Desert Isl. Biol. Lab. 27: 1-3, 1987-88.1988
Booz GW, Feldman GM, Mills JW, Kleinzeller A Cation specificity in cell volume maintenance in rectal gland cells of the dogfish (Squalus acanthias) Bull. Mt. Desert Isl. Biol. Lab. 27: 124-5, 1987-88.1988
Feldman GM, Ziyadeh FN, Booz GW, Kleinzeller A Iso-osmotic cell swelling induced by propionate Kidney Int. 33: 418, 19881988
Stanley CA, Corkey BE, Booz G, Hale DE, Glennon MC, Berry GT Hepatic acyl CoA profiles in riboflavin-induced multiple acyl-CoA dehydrogenase deficiency Pediatr. Res. 348A, 1987.1987
Kleinzeller A, Mills JW, Booz G, Davis SJ Effects of p-chloromercuribenzene sulfonate (PCMBS) on the volume maintenance of dogfish (Squalus acanthias) rectal gland cells Bull. Mt. Desert Isl. Biol. Lab. 26: 163-4, 19861986
Booz G, Beyenbach K, Kleinzeller A Methylamine secretion by isolated perfused renal tubules of the winter flounder (Pseudopleuronectes americanus) Bull. Mt. Desert Isl. Biol. Lab. 20: 66-8, 19801980
Beyenbach KW, Booz G, Kleinzeller A Transepithelial voltages and resistances across isolated perfused renal tubules of the winter flounder Bull. Mt. Desert Isl. Biol. Lab. 20: 78-82, 1980.1980
Booz G, Pew DE, Kleinzeller A The renal handling of D- fructose by the winter flounder (Pseudopleuronectes americanus) Bull. Mt. Desert Isl. Biol. Lab. 18: 26, 1978.1978
Booz G, Goldstein J, Pritchard J, Kleinzeller A The handling of D-mannose at the brush border of the kidney in the winter flounder (Pseudopleuronectes americanus) Bull. Mt. Desert Isl. Biol. Lab. 18: 26-8, 1978.1978
Booz G, Dornbusch J, Goldstein J, Murdaugh A, Forrest JN, Kleinzeller A Experiments on the cell volume regulation in slices of the rectal gland of the dogfish (Squalus acanthias) Bull. Mt. Desert Isl. Biol. Lab. 18:23-5, 1978.1978
Booz G Renal clearance of DMO and methylamine by the winter flounder (Pseudo-pleuronectes americanus) Bull. Mt. Desert Isl. Biol. Lab. 18:25-6, 1978.1978
Booz G, Pritchard JB, Kleinzeller A The renal clearance of D-mannose in the winter flounder Bull. Mt. Desert Isl. Biol. Lab. 17:44-5, 1977.1977

Book Chapter

Zouein FA, LaMarca BB, Booz GW. Protective role of the AT1 Receptor in the Heart: a Biosensor of Stress. In: “Renin Angiotensin System in Cardiovascular Disease” edited by N. S. Dhalla, S. K. Bhullar and A.K. Shah. Springer International Publishing, Jan 3, 2023.2023
Habeichi NJ, Amin G, Massoud G, Diab R, Mericskay M, Booz GW, Zouein FA. Interactions between the Renin Angiotensin Aldosterone System and COVID-19: Pharmacological Interventions. In: Angiotensin in Health and Disease, Pilowsky P. Elsevier2023
Massoud GP, Eid A, Booz GW, Rached L, Yabluchanskiy A, Zouein FA#. (2021). Senolytics in Diseases: Killing to Survive. Springer. (Under review).2021
Zouein FA, LaMarca BB, Booz GW. Protective role of the AT1 Receptor in the Heart: a Biosensor of Stress. In: Renin Angiotensin System in Cardiovascular Disease. Edited by N. S. Dhalla, S. K. Bhullar and A.K. Shah. (Submitted)_2021
Booz GW, Altara R, Didion SP. JAK-STAT Signaling in Cardiovascular Disease. In: JAK-STAT Signaling in Diseases. Editor: R Goswami. CRC Press (March 12, 2020). ISBN 9781138487628. Chapter 7.2020
Abidi E, Kaplan A, Booz GW, Zouein FA. Oxidative Stress in Cardiac Remodeling Post-Ischemia/Reperfusion: Friend or Foe? In: Oxidative Stress in Heart Diseases. Editors: S. Chakraborti, NS Dhalla, NK Ganguly, M Dikshit. Springer, Singapore (2019); pp 253-28; https://doi.org/10.1007/978-981-13-8273-4; Print ISBN 978-981-13-8272-7; Online ISBN 978-981-13-8273-42019
Booz GW Oxidative stress and heart failure: Still a viable therapeutic target? In: García JE, Wright VR eds. Congestive Heart Failure: Symptoms, Causes and Treatment. Hauppauge, New York: Nova Science Publishers; 2010: 89-109.2010
Booz GW, Baker KM. Protein phosphorylation in: Hypertension Primer: The Essentials of High Blood Pressure (4th ed) Lippincott Williams & Wilkins, Baltimore, Maryland, 20082008
Booz, GW. Left ventricular physiology in hypertension in: Comprehensive Hypertension Editors: Y. H. Lip and J. E. Hall. Mosby, 2007, Chapter 10, pp.113-1212007
Booz GW, Baker KM Intracellular signaling and the cardiac renin angiotensin system In: De Mello WC, ed. Renin Angiotensin System and the Heart. West Sussex, England: John Wiley & Sons; 2004: 1-17.2004
Booz GW, Baker KM Protein phosphorylation In. Hypertension Primer: The Essentials of High Blood Pressure (3rd ed), Senior Editors: J. L. Izzo and H. R. Black. Baltimore, Maryland: Lippincott Williams & Wilkins, 2003, pp. 92-96.2003
Booz GW, Baker KM Protein phosphorylation In. Hypertension Primer: The Essentials of High Blood Pressure (2nd ed), Senior Editors: J. L. Izzo and H. R. Black. Baltimore, Maryland: Lippincott Williams & Wilkins, 1999, pp. 71-75.1999

Editorial Commentary

Steinberg SF, Booz GW. In Memoriam Tribute to Michael R. Rosen: A Life Well Lived. J Cardiovasc Pharmacol. 2023 Mar 1;81(3):173-174.2023
Altara R, Booz GW. Central role for BRAF in cardiac hypertrophy: rethinking the pathological-physiological divide. Clin Sci (Lond). 2023 Jan 31;137(2):143-148.2023
Amin G, Massoud G, Fares S, Booz GW, Zouein FA. Colchicine and Acute Coronary Syndromes: A New Trick for an Old Drug? J Cardiovasc Pharmacol. 2022 Nov 1;80(5):631-632.2022
Burashnikov A, Abbate A, Booz GW. Cardiovascular Complications of Anticancer Therapy: A Developing Storm in Medicine. J Cardiovasc Pharmacol. 2022 Oct 1;80(4):491-492.2022
Steinberg S, Booz GW. G Protein Coupled Receptors - receptors with new tricks up their sleeves. J. Cardiovasc Pharmacol. 2022 Sep 1;80(3):325-327.2022
Booz GW, Theofilatos KA. Editorial: Non-coding RNAs in heart failure. Front Cardiovasc Med. 2022 Aug 24;9:1016139.2022
McCandless MG, Altara R, Booz GW, Kurdi M. What Role do Mitochondria Have in Diastolic Dysfunction? Implications for Diabetic Cardiomyopathy and Heart Failure With Preserved Ejection Function. J Cardiovasc Pharmacol. 2022 Apr 1;79(4):399-406.2022
Booz GW, Altara R, Zouein FA. Editorial: Immunomodulatory Approaches in Cardiovascular Diseases. Front Cardiovasc Med. 2022;9:873452.2022
Booz GW, Zouein FA. Science unites a troubled world: Lessons from the pandemic. Eur J Pharmacol. 2021 Jan 5;890:173696. Epub 2020 Oct 29.2021
Zouein FA, Altara R, Massoud GP, Booz GW. The Angiotensin II Type 1(AT1) Receptor and Cardiac Hypertrophy: Did We Have It Wrong All Along? J Cardiovasc Pharmacol. 2021 May 1;77(5):531-535.2021
Fan F, Booz GW, Roman RJ. Aging diabetes, deconstructing the cerebrovascular wall. Aging (Albany NY). 2021 Apr 12;13(7):9158-9159.2021
Booz GW, Massoud GP, Altara R, Zouein FA. Unravelling the impact of intrauterine growth restriction on heart development: insights into mitochondria and sexual dimorphism from a non-hominoid primate. Clin Sci (Lond). 2021 Jul 30;135(14):1767-1772.2021
Altara R, Zouein FA, Booz GW. Untangling the Interplay between Mitochondrial Fission and NF-κB Signaling in Endothelial Inflammation. Hypertension. 2020;76(1):23-252020
Kurdi M, Pollesello P, Booz GW. Levosimendan Comes of Age: Twenty Years of Clinical Use. J Cardiovasc Pharmacol. 2020;76(1):1-3.2020
Zouein FA, Booz GW. Targeting mitochondria to protect the heart: a matter of balance? Clin Sci (Lond). 2020;134:885-888.2020
Lukowski R, Booz GW. Deciphering the dynamics and therapeutic potential of the cardiac cGMP cascade: An update on where we are and what we need to know. J Cardiovasc Pharmacol. 2020;75(5):368-3692020
Abbate A, Booz GW. Cardiovascular Pharmacology of the NLRP3 Inflammasome. J Cardiovasc Pharmacol 2019;74:173-174.2019
Altara R, Booz GW. Editorial: Cardiac Microvascular Endothelium Contribution to Cardiac Myocyte Growth, Structure, and Contractile Function. Front Cardiovasc Med. 2019;6:130.2019
Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis A, Vrints C. Medical Misinformation: Vet the Message! J Cardiovasc Pharmacol. 2019;73:61-62.2019
Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ, Rosenson RS, Sweitzer NK, Timmis A, Vrints C. Medical Misinformation. Circulation. 2019;139:571-572.2019
Booz GW Seizing the Future: What's Next for the Journal of Cardiovascular Pharmacology? J Cardiovasc Pharmacol. 2019;73(1):1-2.2019
Booz GW. A Few Initial Thoughts on Receiving the Baton. J Cardiovasc Pharmacol. 2018;72(1):2.2018
Altara R, Booz GW. Deleting Vascular ADAM17 Sheds New Light on Hypertensive Cardiac Hypertrophy. Hypertension. 2016;68:849-50.2016
Altara R, Didion SP, Booz GW. Conflicting mechanisms of AT2 cardioprotection revealed. Cardiovasc Res. 2016;112:426-8.2016
Kurdi M, Booz GW Carvedilol Protects the Infarcted Heart by Upregulating miR-133: First Evidence that Disease State Affects β-Adrenergic Arrestin-Biased Signaling? J Mol Cell Cardiol. 2014 (In Press).2014
Zouein FA, Kurdi M, Booz GW. HSPA12B and Repairing the Heart: Beauty in Simplicity Cardiovasc Res 2013;99:587-5892013
Kurdi M, Booz GW. Focus on Mitochondria Dysfunction and Dysregulation in Heart Failure: Towards New Therapeutic Strategies to Improve Heart Function Congest Heart Failure 2011;17:255-62011
Booz GW Novel drugs targeting hypertension revisited J Cardiovasc Pharmacol. 2010;56:213-4.2010
Kurdi M, Booz GW. Growing hearts by the bushel Congest Heart Fail. 2008; 14:95-62008
Booz GW. Devising new drugs for the treatment of hypertension--"novel drugs targeting hypertension: renin inhibitors and beyond" J Cardiovasc Pharmacol 2007; 50:1-22007
Booz GW Review of: Heart Failure: Molecules, Mechanisms, and Therapeutic Targets, (Novartis Foundation Symposium 274) Congest Heart Failure 2007;13:62-63.2007
Booz GW. Impact of T lymphocytes on cardiac remodeling in hypertension: more questions than answers Hypertension. 2006; 48:31-22006
Booz GW. Growing old, angiotensin II, cardiac hypertrophy, and death: making the connection with p66Shc Hypertension. 2005; 46:259-602005
Booz GW. The cardiac angiotensin AT2 receptor, what exactly does it do? Hypertension. 43: 1162-1163, 20042004

Presentations

Departmental Seminar, Novel Aspects of Cardiac Remodeling10/2021
Departmental Seminar, Novel Aspects of Cardiac Remodeling10/2021
University of Mississippi Medical Center, Department of Pharmacology and Toxicology, Novel aspects of cardiac remodeling, UMMC04/2019
National and International Invited Seminars/Lectures, Targeting microvascular inflammation in heart failure with preserved ejection fraction, Mini-symposium on the role of inflammation in heart failure, Center for Heart Failure Research at the Oslo University, Norway06/2018
Poster Presentation, Role of STAT3 in Collagen Deposition and Organization in the Normal and Hypertensive Heart, High Blood Pressure Research 2013 Scientific Sessions, New Orleans, LA2013
Platform Presentations, STAT3 Affects Myofibrillar Structure and Its Loss May Contribute to Heart Failure in Hypertension, High Blood Pressure Research 2012 Scientific Sessions, Washington, DC09/2012
State/Local Invited Seminars/Lectures, Redox-Sensitivity of STAT3: Implications for Heart Failure, Department of Pharmacology, University of Mississippi School of Pharmacy, Oxford, MS2012
Seminar, Redox-Sensitivity of STAT3: Implications for Heart Failure, Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS2012
Invited Speaker, Redox-Sensitivity of STAT3: Implications for Heart Failure, Division of Cardiology, Department of Medicine, The Johns Hopkins University, Baltimore, MA2012
Poster Presentation, Acyloxy Nitroso Compounds Inhibit LIF Signaling in Endothelial Cells and Cardiac Myocytes: Evidence That STAT3 Signaling is Redox-Sensitive, High Blood Pressure Research 2012 Scientific Sessions, Washington, DC2012
Poster Presentation, DUAL ROLE OF STAT3 IN HYPERTENSION-INDUCED CARDIAC REMODELING, EB2012 Experimental Biology Meeting, San Diego, CA2012
Seminar, Work In Progress 2011: Understanding JAK-STAT in the Heart, Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS2011
Poster Presentation, Transient Receptor Potential Type C Channels Play a Critical Role in Angiogenesis, EB2011 Experimental Biology Meeting, Washington, DC2011
Platform Presentations, PP2A plays a critical role determining the endothelial cell gene expression profile of leukemia inhibitory factor (LIF), High Blood Pressure Research 2010 Scientific Sessions, Washington D.C.10/2010
Seminar, Hydrogels as a Platform for Stem Cell Delivery to the Heart, Department of Physiology & Biophysics, University of Mississippi Medical Center, Jackson, MS2010
Seminar, Can the protective actions of JAK-STAT in the heart be exploited therapeutically?, Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS2010
Seminar, Uncovering the Versatility of STAT3 in Endothelial Cells, Department of Biochemistry, Jackson, MS2010
Poster Presentation, Nitroxyl activates redox-sensitive stress signaling in endothelial cells and has anti-inflammatory actions, High Blood Pressure Research 2010 Scientific Sessions, Washington, DC2010
Poster Presentation, Sodium Selenate Enhances Endothelial Cell STAT3 Tyrosine Phosphorylation and DNA Binding, ASCB 50th Annual Meeting, Philadelphia, PA2010
Seminar, Mending a Broken Heart: New Approaches to Heart Failure Prevention or Reversal, University of Mississippi Medical Center, SURE Seminar, Jackson, MS2009
State/Local Invited Seminars/Lectures, JAK-STAT Signaling in the Injured and Failing Heart, University of Mississippi Medical Center, Department of Pharmacology and Toxicology, Jackson, MS2008
State/Local Invited Seminars/Lectures, JAK-STAT Signaling in the Injured and Failing Heart, TTUHSC School of Pharmacy, Department of Pharmaceutical Sciences, Amarillo, TX2008
Poster Presentation, Oxidative stress blocks activation of JAK-STAT signaling in cardiac myocytes, XIX World Congress of the ISHR, Bologna, Italy2007
State/Local Invited Seminars/Lectures, JAK-STAT Signaling in the Heart – Novel Insights into Regulation, Department of Cell & Developmental Biology and Anatomy, School of Medicine University of South Carolina, Columbia, SC2007
National and International Invited Seminars/Lectures, PARP Inhibitors in Heart Failure: Translational Medicine in Progress, The 6th Annual Symposium: The Cutting Edge – Cardiology for the Future, Long Beach Memorial Medical Center, Long Beach, CA2007
Poster Presentation, Role for STAT3 in Apoptosis Signaling by Interferon-γ in Human Nonsmall Cell Lung Cancer A549 Cells, ATS International Conference, San Diego, CA2006
Poster Presentation, Parthenolide induces oxidative stress in cardiomyocytes: Differential activation of mitochondrial and NADPH oxidases, Heart Failure Society of America, 9th Annual Scientific Meeting, Boca Raton, FL2005
State/Local Invited Seminars/Lectures, Making the Best of IL-6-Type Cytokines in the Stressed Heart: From STAT3 to SOCS3 to ROS, Department of Physiology & Biophysics, University of Mississippi Medical Center, Jackson, MS2005
Poster Presentation, Anti-inflammatory parthenolide inhibits JAK1 activation in cardiac myocytes but induces oxidative stress, XXVIIth Annual Meeting of the North American Section of the International Society for Heart Research, New Orleans, LA2005
Poster Presentation, Role of STAT1 in the Permissive Effect of Interferon-γ on FAS-Induced Apoptosis of Non-Small Cell Lung Cancer Cells, Montréal, Québec, Canada, American College of Chest Physicians 2005 Meeting (CHEST)2005
Poster Presentation, Rescue of Internalization-Impaired Angiotensin II AT1 Mutants by β-Arrestin Overexpression, American College of Cardiology, Annual Scientific Session, New Orleans2004
Poster Presentation, Molecular Mechanisms of IL-6-Related-Cytokine STAT3 Regulation in Cardiac Myocytes, Heart Failure Society of America, 8th Annual Scientific Meeting, Toronto, Ontario, Canada2004
Poster Presentation, The Anti-Inflammatory Agent Parthenolide has Differential and Independent Effects on Jak-STAT and ERK Signaling in Cardiac Myocytes, Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, San Antonio, TX2004
Poster Presentation, Interferon-γ has a Potent Cytostatic Effect via STAT1 Activation on the A549 Human Lung Cancer Cell Line, American Society for Cell Biology, Washington, DC2004
Poster Presentation, Activation of STAT1 BY IFN-γ Inhibits Growth of Human Non-Small Cell Lung Cancer Cells, American College of Chest Physicians 2004 Meeting (CHEST), Seattle, Washington2004
Poster Presentation, Role for β-arrestins, but not GRKs, in angiotensin II-induced internalization of AT1, AHA Scientific Conference on Molecular Mechanisms of Growth, Death and Regeneration in the Myocardium: Basic Biology and Insights into Ischemic Heart Disease and Heart Failure, Salt Lake, UT2003
Poster Presentation, Angiotensin II modulates gp130 signaling in cardiac myocytes by tyrosine phosphatase activation, American College of Cardiology, Annual Scientific Sessions, Orlando, FL2001
Poster Presentation, Endothelin-1 inhibits activation of the LIF receptor in cardiomyocytes, Annual Fall Conference and Scientific Sessions of the Council for High Blood, Chicago IL2001
Seminar, Cardiac Actions of Angiotensin II, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL1998
State/Local Invited Seminars/Lectures, Opposing Roles of the Angiotensin II Receptor Subtypes in Cardiac Hypertrophy, Dept. of Physiology, University of Florida, School of Medicine, Gainesville, FL1997
Seminar, Opposing Roles of the Angiotensin II Receptor Subtypes in Cardiac Hypertrophy, Weis Center for Research, Danville, PA1997
State/Local Invited Seminars/Lectures, Opposing Roles of the Angiotensin II Receptor Subtypes in Cardiac Hypertrophy, College of Pharmacy, Division of Pharmacology and Experimental Therapeutics, University of Kentucky, Lexington, KY1997
State/Local Invited Seminars/Lectures, Opposing Roles of the Angiotensin II Receptor Subtypes in Cardiac Hypertrophy, Children’s Hospital Medical Center, Division of Pulmonary Medicine, Allergy, and Clinical Immunology, University of Cincinnati, Cincinnati, OH1997
Seminar, Angiotensin II-Induced Cardiac Hypertrophy: A Role for the Type II Receptor?, Weis Center for Research, Danville, PA1995
Platform Presentations, AT2 Receptor Blockade Augments Angiotensin II-Induced Cardiomyocyte Hypertrophy, Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, New Orleans, LA1995
State/Local Invited Seminars/Lectures, Role of Angiotensin II in Cardiac Hypertrophy and Remodeling, Dept. of Medical Pharmacology and Toxicology, Texas A&M University School of Medicine, Colege Station, TX1995
Seminar, Involvement of Protein Kinase C and Calcium in Angiotensin II-Induced Mitogenesis of Cardiac Fibroblasts, Weis Center for Research, Danville, PA1994
Poster Presentation, Role of Protein Kinase C in Angiotensin II-Induced Mitogenesis of Neonatal Rat Cardiac Fibroblasts, APS Conference, Signal Transduction and Gene Regulation, San Francisco, CA1994
Seminar, Role of PKC in the Mitogenic Effect of AII on Rat Cardiac Fibroblasts, Weis Center for Research, Danville, PA1993
Poster Presentation, Angiotensin II Binding Sites on Hepatocyte Nuclei, FASEB, Anaheim, CA1992
Platform Presentations, N-Carbobenzoxy-glycyl-L-phenylalaninamide Inhibits Both Basal and Contraction-Initiated 2-Deoxyglucose Uptake by Frog Muscle, FASEB, Washington, DC1990

Honors, Awards, and Recognition

Guest Editor, Special issue “Therapeutic targets and pharmacological treatment of COVID-19”, European Journal of Pharmacology, 20202020
Co-Editor (with Dr. Altara), Frontiers in Cardiovascular Medicine, Review Series: The Diagnosis and Therapeutic Options for Cardiomyopathy (Dr. Fouad Zouein, Editor)2020
Guest Editor, Cardiac Microvascular Endothelium Contribution to Cardiac Myocyte Growth, Structure, and Contractile Function in Frontiers in Cardiovascular Medicine: Cardiovascular Genetics and Systems Medicine (Raffaele Altara, PhD and George W. Booz, PhD), 20192019
Editor-in-Chief, Journal of Cardiovascular Pharmacology, 2019 – present2019
Top Reviewer, 2018, Hypertension2018
Top Reviewer, 2018, Cardiovascular Research2018
Section Editor, Special Issue 50th Anniversary European Journal of Pharmacology: Cardiovascular pharmacology (Booz and Dr. Jovanovic, University of Dundee), 20182018
Section Editor, Special Issue 50th Anniversary European Journal of Pharmacology: Regenerative pharmacology (Booz and Dr. Los, Linköping University), 20182018
Top Reviewer, 2017, Hypertension2017
Editorial Board, Clinical Science, 2015-present2015
Editor (for Reviews), European Journal of Pharmacology, 2015 – present2015
Editorial Board, Cardiovascular Research, 2014-present2014
Associate Editor, Frontiers in Cardiovascular Medicine (Cardiovascular Genetics and Systems Medicine), 2014 – present2014
Top Ten Reviewer 2014, Hypertension2014
Associate Editor, Journal of Cardiovascular Pharmacology, Drugs in the Pipeline section, 2013 – 20182013
Editorial Board, European Journal of Pharmacology, 2013-20152013
Faculty Member (Cardiovascular Pharmacology), 2013-present, F1000Prime2013
Top Reviewer, 2013, Hypertension2013
Certificate of appreciation as a top reviewer, 2012, Hypertension2012
Guest Editor, Congestive Heart Failure Review Series - Mitochondria and Heart Failure, 20112011
Certificate of Appreciation 100 Manuscripts, Cardiovascular Research2011
Guest Editor, Journal of Cardiovascular Pharmacology, Review Series - Novel Drugs Targeting Hypertension: A Follow Up, 20102010
Excellence in Research Award, Gold Level, University of Mississippi Medical Center2010
Senior Editor, Congestive Heart Failure, 2009 – 20132009
Editorial Board, Free Radical Biology and Medicine, 2009-20202009
Excellence in Research Award, Bronze Level, University of Mississippi Medical Center2009
Editorial Board, Cardiovascular Research, 2008-20122008
Section Editor, Congestive Heart Failure: Translational Research, 2007 – 20132007
Guest Editor, Journal of Cardiovascular Pharmacology, Review Series - Novel Drugs Targeting Hypertension: Renin Inhibitors and Beyond, 20072007
Editorial Board, Congestive Heart Failure, 2005-20132005
Editorial Board, Journal of Cardiovascular Pharmacology, 2004-present2004
Fellow of the American Heart Association, 2004-present, American Heart Association2004
Top Ten Reviewer 2004, Hypertension2004
Editorial Board, Hypertension, 2003-present2003
Fellowship, Thomas Jefferson University1990
Elected Lifetime Full Member, Mt. Desert Island Biological Laboratory1990
Fellowship, Mt. Desert Island Biological Laboratory1990
University Fellowship, Thomas Jefferson University1989
Speck Fellowship, Thomas Jefferson University1988
Summer Fellowship, American Heart Association, Maine Chapter1988
Student Scholarship, Mt. Desert Island Biological Laboratory1988
Foerderer Fellow, Thomas Jefferson University1986
Dean's List (1983 - 1986), Drexel University1983
Student Scholarship, Mt. Desert Island Biological Laboratory1977
National Research Service Award (1977 - 1980), University of Pennsylvania1977
Dean's List (1972 - 1976), St. Joseph's University1972
Presidential Scholarship (1972 - 1976), St. Joseph's University1972

Professional Membership and Service

Heart Group: Editors-in-chief of the major cardiovascular scientific journals, Member2019 - Present
American Heart Association (grant review panel), Committee Chairperson, Grant Reviewer; Cardiac Bio Reg - BSci 3: Spring 2015, Spring 2016, Fall 20162015 - 2016
Department of Defense, Member, FY15 Peer Reviewed Medical Research Program (PRMRP) for the Department of Defense Congressionally Directed Medical Research Programs: Peer review panel - Programs in cardiovascular health, Fall 20152015
Biochemical Society, Member2015 - Present
Cardiovascular Research, Editorial Review Board Member2014 - Present
Journal of Cardiovascular Pharmacology, Associate Editor2013 - 2019
European Journal of Pharmacology, Editorial Board Member2013 - 2015
American Heart Association (grant review panel), Committee Co-Chair, Grant Reviewer; Cardiac Bio Reg - BSci 3: Spring 2013, Fall 2013, Spring 2014, Fall 20142013 - 2014
European Cytokine Society, Member2012 - 2014
National Heart, Lung, and Blood Institute (peer review group), Member, P50 Review - RFA-NHLBI Research Centers at Minority Serving Institutions - Phase II2012
National Heart, Lung, and Blood Institute, Reviewer, Grant Proposal, Ad hoc; Basic Research in Calcific Aortic Valve Disease2012
American Heart Association (grant review panel), Member, Grant Reviewer; Cardiac Bio BSc 1: Fall 20122012
National Heart, Lung, and Blood Institute, Member, Grant Reviewer; Special Emphasis Panel – Research Centers at Minority-Serving Institutions 20112011
Congestive Heart Failure, Guest Editor, Review Series - Mitochondria and Heart Failure2011
Women’s Health Research Center, University of Mississippi Medical Center, Member2010 - 2014
American Institute of Biological Sciences - FAMRI (Flight Attendant Medical Research Institute), Site Visit, FAMRI Julius B. Richmond Center of Excellence at the American Academy of Pediatrics, Elk Grove Village, Illinois2010
Journal of Cardiovascular Pharmacology, Guest Editor, Review Series - Novel Drugs Targeting Hypertension: A Follow Up2010
Free Radical Biology and Medicine, Editorial Board Member2009 - 2020
Center for Excellence in Cardiovascular Renal Research, University of Mississippi Medical Center, Member2009 - 2015
Congestive Heart Failure, Senior Editor2009 - 2013
American Heart Association (grant review panel), Member, Grant Reviewer; Cardiac Biology/Regulation - Basic & Clinical/Translational: Region 3, Spring 2009 & Spring 2010; Region 2 and 3, Fall 2010; Region 2 and 3, Spring 2011
Region 2 and 3, Fall 2011; Region 2 and 3, Spring 2012
2009 - 2012
National Heart, Lung, and Blood Institute (peer review group), P30 Review (ARRA funds)2009
Society for Free Radical Biology and Medicine, Member2009 - Present
Cardiovascular Research, Editorial Review Board Member2008 - 2012
Congestive Heart Failure, Section Editor, Translational Research2007 - 2013
Journal of Cardiovascular Pharmacology, Guest Editor, Review Series - Novel Drugs Targeting Hypertension: Renin Inhibitors and Beyond2007
Congestive Heart Failure, Editorial Review Board Member2005 - 2013
NHLBI, Committee Member, Program Project Review Panel2004 - 2007
American Society for Cell Biology, Member2004 - 2016
Heart Failure Society of America, Member2004 - 2016
Journal Of Cardiovascular Pharmacology, Editorial Board Member2004 - 2013
American Thoracic Society, Member2004 - 2011
American Institute of Biological Sciences - FAMRI (Flight Attendant Medical Research Institute), Member, Grant Reviewer; Panel - Molecular basis of cancers associated with second hand smoke: 2005; Panel - Molecular basis of diseases (non-cancer) associated with second hand smoke: 2004, 2006, 2007; Panel - Cardiovascular Diseases: 20082004 - 2008
American Society of Hypertension, Member2003 - 2011
The Texas Chapter of the American Society of Hypertension2003 - 2008
American Stroke Association, Member2003 - Present
Council for High Blood Pressure Research, Member2003 - Present
Hypertension, Editorial Review Board Member2003 - Present
New York Academy of Sciences, Member1995 - 2011
International Society for Heart Research, Member1994 - 2016
American Physiological Society, Member1991 - 2016
American Heart Association, Member1991 - Present
Mount Desert Island Biological Laboratory, Associate 1977 – 1990, Full Lifetime 1990 – present, Member1977 - Present

Committee Service

Doctoral Examination Board, Sabah Hammoud, Doctoral Student, Title of dissertation: Heart Rate Variability in Physiological and Pathological Conditions, Radboud Universiteit, Nijmegen, Netherlands, Member2023 - Present
Thesis Committee, Quinesha Williams, Doctoral Student, Experimental Therapeutics and Pharmacology, School of Graduate Studies in the Health Sciences, University of Mississippi Medical Center., Member2023 - Present
MEDICAL CENTER-ANIMAL CARE AND USE, Member2022 - Present
SCHOOL OF GRADUATE STUDIES IN THE HEALTH SCIENCES-GRADUATE COUNCIL, Member2022 - Present
Thesis Committee, Xing Fang, Doctoral Student, Experimental Therapeutics and Pharmacology, School of Graduate Studies in the Health Sciences, University of Mississippi Medical Center, Member2021 - Present
Thesis Committee, Nathan Campbell, Doctoral Student, Experimental Therapeutics and Pharmacology, School of Graduate Studies in the Health Sciences, University of Mississippi Medical Center, Member2021 - Present
Thesis Committee, Maya Dia, Doctorante, IHU OPERA-CARDIOPROTECTION, Laboratoire CarMeN (Cardiovasculaire, Métabolisme, Diabétologie et Nutrition), Unité INSERM U1060/Université-Lyon1, Member2020 - 2020
Member of the Committee for Doctoral degree defense, Rana Ghali: The Role of Interleukin 33 (IL-33) Administration in Cardiac Function Post-Myocardial Infarction. Université de Paris, Member2020 - 2020
Thesis Committee, Owen Herrock, Doctoral Student, Experimental Therapeutics and Pharmacology, School of Graduate Studies in the Health Sciences, University of Mississippi Medical Center, Member2020 - 2023
Thesis Committee, Letao Fan, Doctoral Student, Experimental Therapeutics and Pharmacology, School of Graduate Studies in the Health Sciences, University of Mississippi Medical Center, Member2019 - 2021
Thesis Committee, Shaoxun Wang, Doctoral Student, Experimental Therapeutics and Pharmacology, School of Graduate Studies in the Health Sciences, University of Mississippi Medical Center, Member2019 - Present
Thesis Committee, Joshua R. Jefferson, Master’s degree in Health Sciences, Department of Health Sciences in the School of Health Related Professions, University of Mississippi Medical Center, Member2019 - 2020
Graduate Recruitment Committee, UMMC Dept. Pharmacology & Toxicology, Member2019 - Present
Graduate Program Committee, UMMC Dept. Pharmacology & Toxicology, Member2019 - Present
Faculty Recruitment Committee, UMMC Dept. Pharmacology & Toxicology2018 - Present
Self-Study Committee, UMMC Dept. Pharmacology & Toxicology, Member2018 - 2018
Strategic Planning Committee (Department of Pharmacology and Toxicology), Member2017 - 2019
Thesis Committee, Xiaochen "Alex" He, Doctoral Student, Medical Pharmacology School of Graduate Studies in the Health Sciences, University of Mississippi Medical Center, Member2015 - 2018
Thesis Committee, Barak Gunter, Doctoral Student, Psychiatry and Human Behavior, School of Graduate Studies in the Health Sciences, University of Mississippi Medical Center, Member2014 - 2017
Thesis Committee, Kandis V. Backus, Doctoral Student, Medical Pharmacology, School of Graduate Studies in the Health Sciences, University of Mississippi Medical Center, Member2013 - 2013
Professional Education Committee, Department of Pharmacology and Toxicology, The University of Mississippi Medical Center, Member2012 - 2016
Faculty Recruitment Committee, Department of Pharmacology and Toxicology, The University of Mississippi Medical Center, Chair2012 - 2017
Graduate Program Committee, Dept. Pharmacology, The University of Mississippi Medical Center, Member2012 - 2014
Thesis Committee, Fouad A. Zouein, Doctoral Student, Medical Pharmacology, School of Graduate Studies in the Health Sciences, University of Mississippi Medical Center, Chair2012 - 2013
Thesis Committee, Carlos Zgheib, Doctoral Student, Medical Pharmacology School of Graduate Studies in the Health Sciences, University of Mississippi Medical Center, Chair2011 - 2012
Society for Free Radical Biology and Medicine (SFRBM) Nominations/Leadership Development Committee, Member2010 - 2018
Pharmacology Education/Graduate Curriculum Committee, Department of Pharmacology and Toxicology, The University of Mississippi Medical Center, Member2010 - 2012
Faculty Search Committee, Department of Pharmacology and Toxicology, The University of Mississippi Medical Center, Member2010 - 2010
Admissions Committee for the Graduate Program in Pharmacology and Toxicology, The University of Mississippi Medical Center, Member2010 - 2012
Thesis Committee, Chetan Patil, Doctoral Student, Medical Pharmacology, School of Graduate Studies in the Health Sciences, University of Mississippi Medical Center, Member2009 - 2012
Institutional Biosafety Committee, Texas A&M University, Member2007 - 2008
Thesis Committee, Joana Dado, Masters, Graduate School of Biomedical Sciences, The Texas A&M University System Health Science Center College of Medicine, Member2007 - 2008
Institutional Biosafety Committee (Ex-Officio), Texas A&M University, Member2006 - 2007
Research and Development Committee of the Central Texas Veterans Health Care System, Member2006 - 2008
Subcommittee on Research Safety of the Central Texas Veterans Health Care System, Chair2006 - 2008
Public Affairs Committee (Alternate), The American Physiological Society, Member2005 - 2006
Subcommittee on Research Safety of the Central Texas Veterans Health Care System, Member2004 - 2006
Radioisotope Protocol Review Committee of the Central Texas Veterans Health Care System, Member2004 - 2008
Publications Committee, Council for High Blood Pressure Research, Member2003 - 2006
Institutional Review Board (Human Studies Subcommittee) of the Central Texas Veterans Health Care System, Member2000 - 2006

Community Service

Research Day, School of Graduate Studies in the, Poster Judge2015 - 2015
Grants In Progress/Grant Masters Club, Participant2009 - 2010
Research Day, School of Graduate Studies in the Health Sciences, Poster Judge2009 - 2009
3rd Annual Cardiovascular Research Institute Retreat, Poster Judge2007 - 2007
2nd Annual Cardiovascular Research Institute Retreat, Poster Judge2006 - 2006
10th Annual Heath Science Center Research Symposium, Poster Judge2005 - 2005
Heart and Lung Focus Group, Division of Molecular Cardiology, Texas A&M Univ. System Health Science Center, Organizer and Chair2004 - 2005

Other Service

NIH Scientific Review Group (ZRG1 RCCS-C) Special Emphasis Panel/Scientific Review Group, Co-chair, Reviewer07/2023 - Present
Intramural Research Support Program (IRSP)07/2023 - Present
NIH Scientific Review Group (ZRG1 RCCS-R 02 M), Member Conflict: Respiratory, Cardiac, and Circulatory Sciences, Chair, Reviewer03/2023 - Present
Clinical Research Support Sub-core for the MS CEPR COBRE (Phase 2), Director2021 - Present
Review panel for the Department of Defense Congressionally Directed Medical Research Programs (CDMRP), Peer Reviewed Medical Research Program (PRMRP), Focus Program Award Mitochondria (FP-MTD).10/2020 - 10/2020
Center for Medicinal Cannabis Research (CMCR), Grant Reviewer (ad hoc)06/2020 - 07/2020
Journal of Cardiovascular Pharmacology, Editor-In-Chief2019 - Present
SFRBM's 22th Annual Meeting, 2015, Abstract Reviewer/Grader2015 - 2015
Clinical Science, Editorial Board Member2015 - Present
European Journal of Pharmacology, Editor (for Reviews)2015 - Present
FY15 Peer Reviewed Medical Research Program (PRMRP) for the Department of Defense Congressionally Directed Medical Research Programs - Discovery Cardiovascular Health2015 - 2015
FAMRI Richmond Center of Excellence progress report2015 - 2015
Cardiovascular Research, Editorial Board Member2014 - Present
Frontiers in Cardiovascular Medicine (Cardiovascular Genetics and Systems Medicine), Associate Editor2014 - Present
Italian Ministry of Health - National Call Biomedical Research2014 - 2014
AHA Collaborative Science Award Letter of Intent, 20142014 - 2014
European Society of Hypertension and International Society of Hypertension, 2014 Joint Meeting, Abstract Reviewer/Grader2014 - 2014
FAMRI Richmond Center of Excellence progress report, Grant Reviewer (ad hoc)2014 - 2014
French National Research Agency, generic call for proposals 2014: pre-proposal evaluation, Grant Reviewer (ad hoc)2014 - 2014
The South Dakota State University College of Pharmacy, Grant Reviewer (ad hoc)2014 - 2014
European Journal of Pharmacology, Editorial Board Member2013 - 2015
Journal of Cardiovascular Pharmacology, Associate Editor2013 - 2018
Council for High Blood Pressure Research Scientific Sessions 2013, Session Co-Chair, Cardiac Hypertrophy and Dysfunction2013 - 2013
FAMRI Richmond Center of Excellence progress report, Grant Reviewer (ad hoc)2013 - 2013
French National Research Agency, Grant Reviewer (ad hoc)2013 - 2013
Pathophysiology Section of the French National Research Agency in the Exploratory and Emerging Research Department, Grant Reviewer (ad hoc)2013 - 2013
Genomics and Immunology Research Laboratory within the USDA Beltsville Human Nutrition Research Center, project plan “Health promoting roles of food bio-active phenolic compounds on obesity-altered heart and kidney functions and physiology”, Grant Reviewer (ad hoc)2013 - 2013
FAMRI Center of Excellence Award (Re-Review), Grant Reviewer (ad hoc)2012 - 2012
French National Research Agency, Call for projects: White - SVSE 1 - Physiology, pathophysiology, public health, Grant Reviewer (ad hoc)2012 - 2012
CARIPARO Foundation, Grant Reviewer (ad hoc)2012 - 2012
AIBS/FAMRI, Clinical Innovator Award, Grant Reviewer (ad hoc)2012 - 2013
Italian Ministry of Health, 2011,2012,2013, Grant Reviewer (ad hoc)2011 - 2013
French National Research Agency, “BlueSky and Young Researchers Programmes”, Grant Reviewer (ad hoc)2011 - 2011
Italian Ministry of Health, 'Young Italian Researchers Call', Grant Reviewer (ad hoc)2010 - 2010
Free Radical Biology and Medicine, Editorial Board Member2009 - 2020
Congestive Heart Failure, Senior Editor2009 - 2013
Society for Free Radical Biology and Medicine Annual Meeting, Abstract Reviewer/Grader2009 - 2014
GENOPAT Program - Molecular Pathophysiology: From Rare to Common Diseases, Proposals submitted to French National Research Agency (Inserm/French National Institute for Health and Medical Research) in association with the French Association against Myopathies, Grant Reviewer (ad hoc)2009 - 2009
Italian Ministry of Health, Directorate for Health and Technologies Research, Grant Reviewer (ad hoc)2009 - 2009
Cardiovascular Research, Editorial Board Member2008 - 2012
Congestive Heart Failure, Section Editor: Translational Research2007 - 2013
FAMRI Re-Review, Grant Reviewer (ad hoc)2007 - 2007
The National Research Program on Cardiovascular Diseases (Inserm/French National Institute for Health and Medical Research) and The French Society of Arterial Hypertension, Grant Reviewer (ad hoc)2007 - 2007
FAMRI Center of Excellence Award, Grant Reviewer (ad hoc)2006 - 2006
National Medical Research Council (Singapore), Grant Reviewer (ad hoc)2006 - 2006
Congestive Heart Failure, Editorial Board Member2005 - 2007
U.S. Civilian Research & Development Foundation (CRDF), Grant Reviewer (ad hoc)2005 - 2005
AIBS: US Army Medical Research and Materiel Command (USAMRMC), Grant Reviewer (ad hoc)2005 - 2008
Journal of Cardiovascular Pharmacology, Editorial Board Member2004 - 2013
AHA Scientific Sessions, Abstract Reviewer/Grader2004 - 2010
Hypertension, Editorial Board Member2003 - Present
Inter-American Society of Hypertension Scientific Meetings, Abstract Reviewer/Grader2003 - 2009
Annual Fall Conference and Scientific Sessions of the Council for High, Abstract Reviewer/Grader2003 - 2008
Ad Hoc Journal Reviewer: Journal of Molecular and Cellular Cardiology, Circulation, Journal of Clinical Investigation, Circulation Research, American Journal of Physiology: Heart and Circulatory Physiology, American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, Journal of Applied Physiology, Expert Opinion on Emerging Drugs, The International Journal of Biochemistry and Cell Biology, American Journal of Hypertension, Molecular and Cellular Biochemistry, Regulatory Peptides, Journal of the American College of Cardiology, Biochemical Pharmacology, Acta Pharmacologica Sinica, American Journal of Pathology, American Journal of Physiology: Cell Physiology, Physiological Genomics, American Journal of Physiology: Endocrinology and Metabolism, British Journal of Pharmacology, Endocrine, Clinical and Experimental Pharmacology and Physiology, Endocrinology, Apoptosis, Cardiovascular Drugs and Therapy, Experimental Cell Research, European Journal of Pharmacology, Phytotherapy Research, Experimental Gerontology, Experimental Lung Research, Circulation: Heart Failure, Journal of Cellular Physiology, Biomedical Materials, PLOS ONE, European Journal of Heart Failure, JAK STAT, Journal of the Saudi Heart Association, Pharmacological Research.2000 - Present
VA Merit Review Proposals, Grant Reviewer (ad hoc)1994 - 2000

Teaching Experience

PH652, Medicine, Course, Instructor, Advanced Topics in PharmacologyAnnual 2020
PH724, Graduate, Course, Lecturer, Experimental Design & Methods (Course Director, 2021 - present), ONGOINGAnnual 2016
Pharm790, Graduate, Course, Course Presenter, Special Topics in Pharmacology and ToxicologySpring 2010 - 2015
PH626/726, Dentistry/Graduate, Course, Lecturer, Pharmacology (Dental)/Fundamental Pharmacology, ONGOINGSpring 2010
PH652, Medicine, Course, Course Presenter, Advanced Topics in PharmacologySpring 2009 - 2015
PH723, Graduate, Course, Lecturer, Mechanisms of Drug Action (Course Director, 2014 - 2015, 2019 - present), ONGOINGAnnual 2009
PH620/722, Medicine/Graduate, Course, Lecturer, Introduction To Pharmacology & Therapeutics (Medical Pharmacology), ONGOINGAnnual 2009
MSCI612, Graduate, Course, Course Director, Current Topics in Cell Signaling (TAMUS HSC) 2006 - 2006
MSCI602, Graduate, Course, Lecturer, Principles of Medical Science (TAMUS HSC) 2004 - 2007
MPHY901, Medicine, Course, Lecturer, Medical Physiology 2004 - 2004
MSCI689, Graduate, Course, Lecturer, Advanced Topics in Cell Signaling (TAMUS HSC) 2003 - 2005
MPHY606, Medicine/Graduate, Course, Lecturer, Advanced Cardiovascular Biology (TAMUS HSC) 2003 - 2007
MSCI601, Graduate, Course, Lecturer, Principles of Medical Science (TAMUS HSC) 2003 - 2007
Course, Lab Presenter, Blood Bank Techniques Laboratory, Thomas Jefferson University 1989 - 1989

Directed Student Learning

Research Advisor, Advised: Ghadir Amin2023 - Present
Supervised Research (summer), medical student, Advised: Daniel G. Thomas2020 - 2020
Supervised Research (summer), medical student MSRP, Advised: Alex N. Smith2020 - 2023
Supervised Research (summer), medical student MSRP, Advised: Daniel Kennedy2019 - 2019
Supervised Research (summer), medical student MSRP, Advised: Brett Bowling2019 - 2019
Supervised Research (summer), SURE Student, Advised: Daniel Azubuike2019 - 2019
Postdoctoral Fellow, Advised: Raffaele Altara2015 - 2017
Postdoctoral Fellow, Advised: Fouad Zouein2015 - 2016
Supervised Research, Graduate Student, Medical Pharmacology, Advised: Venkata Vaka2014 - 2015
Supervised Research, Graduate Student, Medical Pharmacology, Advised: Venkata Vaka2013 - 2013
Supervised Research, SURE Student, Advised: Charles Powell2013 - 2013
Preclinical Advisor, 3/4M1 and 3/4M2 students per year2013 - Present
Supervised Research, SURE Student, Advised: Charles Powell2012 - 2012
Supervised Research, Medical Pharmacology, Advised: Barak Gunter2012 - 2012
Sepervised Research, 3rd year medical student, Alfaisal University, College of Medicine, Advised: Nour Alshaaer2011 - 2011
Supervised Research, 4th year medical student, Alfaisal University, College of Medicine, Advised: Hani Alturkmani2011 - 2011
Supervised Research, 3rd year medical student, Alfaisal University, College of Medicine, Advised: Hani Alturkmani2010 - 2010
Dissertation Defense Committee Chair, Importance of STAT3 in Hypertension-Induced Remodeling of the Heart
Advised: Fouad Zouein
2010 - 2013
Supervised Research, Advised: Fouad Zouein2009 - 2010
Supervised Research, Master's Student, Holy Spirit University, Advised: Rony Chidiac2009 - 2009
Supervised M1 Medical Student Summer Research, Advised: Joshua Burkhart2009 - 2009
Supervised Summer Undergraduate Research, Advised: Qianli (Lee) Tian2009 - 2009
Postdoctoral Fellow, Advised: Thomas Sebastian2009 - 2011
Dissertation Defense Committee Chair, Regulation of Inflammatory JAK-STAT Signaling: Implications For Cardiac Repair and Remodeling
Advised: Carlos Zgheib
2009 - 2012
Supervised Research, Graduate Student, Medical Pharmacology, Advised: Marilyn Burke2009 - 2009
Supervised Research, Masters Student, Holy Spirit University, Lebanon, Advised: Hovig Khachadourian2008 - 2008
Supervised Research,Masters Student, Holy Spirit University, Lebanon, Advised: Carlos Zgheib2008 - 2008
Supervised Research, Masters Student, Holy Spirit University, Lebanon, Advised: Youssef Bou Assy2007 - 2007
Supervised Research, Masters Student, Holy Spirit University, Lebanon, Advised: Marita Fassoul2007 - 2007
Supervised Research, Masters Student, Holy Spirit University, Lebanon, Advised: Carlos Zgheib2007 - 2007
Supervised Research, College Student, Advised: Samantha Bruce2004 - 2005
Supervised Research, College Student, Advised: Nathan Guthrie2004 - 2004
Supervised Research, College Student, Advised: William White2004 - 2005
Postdoctoral Fellow, Advised: Mazen Kurdi2004 - 2008
Supervised Research, Summer Student, Advised: Kelly Culver2003 - 2003

Fellows supervised

Cardiac Research, Program Director, 4 fellows supervised, Molecular Biology and Cell Signaling01/2004 - 06/2017
Pulmonary and Critical Care Medicine, Training Faculty, 3 fellows supervised, Molecular Biology and Cellular Signaling01/2003 - 01/2006